Search

Your search keyword '"Krudsood S"' showing total 258 results

Search Constraints

Start Over You searched for: Author "Krudsood S" Remove constraint Author: "Krudsood S"
258 results on '"Krudsood S"'

Search Results

101. Definition of hyperparasitemia in severe falciparum malaria should be updated.

102. C-terminal polymorphism of Plasmodium falciparium merozoite surface protein-1 (MSP-1) from Tak Province, Thailand.

103. Thelazia callipaeda: a human case report.

104. Use of buffy coat thick films in detecting malaria parasites in patients with negative conventional thick films.

105. The first reported case of autochthonous cutaneous leishmaniasis in Thailand.

106. Evaluation of the NOW Malaria Immunochromatographic Test for Quantitative Diagnosis of Falciparum and Vivax Malaria Parasite Density.

107. Efficacy and safety of artemether-lumefantrine in the treatment of acute, uncomplicated Plasmodium falciparum malaria: a pooled analysis.

108. Factors associated with acute renal failure in falciparum malaria infected patients.

109. Awareness and practices of self-management and influence factors among individuals with type 2 diabetes in urban community settings in Anhui Province, China.

110. Directly observed therapy with primaquine to reduce the recurrence rate of plasmodium vivax infection along the Thai-Myanmar border.

111. Modulating effects of plasma containing anti-malarial antibodies on in vitro anti-malarial drug susceptibility in Plasmodium falciparum.

112. Long term primaquine administration to reduce Plasmodium falciparum gametocyte transmission in hypoendemic areas.

113. Arterolane, a new synthetic trioxolane for treatment of uncomplicated Plasmodium falciparum malaria: a phase II, multicenter, randomized, dose-finding clinical trial.

114. Changes in platelet count in uncomplicated and severe falciparum malaria.

115. Intravenous ibuprofen (IV-ibuprofen) controls fever effectively in adults with acute uncomplicated Plasmodium falciparum malaria but prolongs parasitemia.

116. Primaquine administration after falciparum malaria treatment in malaria hypoendemic areas with high incidence of falciparum and vivax mixed infection: pros and cons.

117. Appropriate time for primaquine treatment to reduce Plasmodium falciparum transmission in hypoendemic areas.

118. Vitamin K injection in spontaneous bleeding and coagulopathy in severe malaria: pros and cons.

119. Plasmodium falciparum genome-wide scans for positive selection, recombination hot spots and resistance to antimalarial drugs.

120. Ursodeoxycholic acid and artesunate in the treatment of severe falciparum malaria patients with jaundice.

121. Management of Plasmodium knowlesi malaria without PCR confirmation.

122. Whole blood angiopoietin-1 and -2 levels discriminate cerebral and severe (non-cerebral) malaria from uncomplicated malaria.

123. The clinical efficacy of artemether/lumefantrine (Coartem).

124. Use of peroxisome proliferator-activated receptor gamma agonists as adjunctive treatment for Plasmodium falciparum malaria: a randomized, double-blind, placebo-controlled trial.

125. Misclassification of drug failure in Plasmodium falciparum clinical trials in southeast Asia.

126. Malaria diagnosis: a brief review.

127. Role of known molecular markers of resistance in the antimalarial potency of piperaquine and dihydroartemisinin in vitro.

128. Serum angiopoietin-1 and -2 levels discriminate cerebral malaria from uncomplicated malaria and predict clinical outcome in African children.

129. Dynamic changes in white blood cell counts in uncomplicated Plasmodium falciparum and P. vivax malaria.

130. Hyponatraemia and hypokalaemia in adults with uncomplicated malaria in Thailand.

131. Defective erythropoietin production and reticulocyte response in acute Plasmodium falciparum malaria-associated anemia.

132. Suppression of Plasmodium falciparum by serum collected from a case of Plasmodium vivax infection.

133. Gametocyte clearance in uncomplicated and severe Plasmodium falciparum malaria after artesunate-mefloquine treatment in Thailand.

134. High-dose primaquine regimens against relapse of Plasmodium vivax malaria.

135. Quantitation of cell-derived microparticles in plasma using flow rate based calibration.

136. Heritability of P. falciparum and P. vivax malaria in a Karen population in Thailand.

137. Efficacy of Artequick versus artesunate-mefloquine in the treatment of acute uncomplicated falciparum malaria in Thailand.

138. Predictive score of uncomplicated falciparum malaria patients turning to severe malaria.

139. Dose ranging studies of new artemisinin-piperaquine fixed combinations compared to standard regimens of artemisisnin combination therapies for acute uncomplicated falciparum malaria.

140. Clinical efficacy of chloroquine versus artemether-lumefantrine for Plasmodium vivax treatment in Thailand.

141. Efficacy of atovaquone-proguanil for treatment of acute multidrug-resistant Plasmodium falciparum malaria in Thailand.

142. Significant association between TNF-alpha (TNF) promoter allele (-1031C, -863C, and -857C) and cerebral malaria in Thailand.

143. Independent evolution of pyrimethamine resistance in Plasmodium falciparum isolates in Melanesia.

144. Reduction of parasite levels in patients with uncomplicated malaria by treatment with HE2000.

145. In vitro antimalarial activity of azithromycin, artesunate, and quinine in combination and correlation with clinical outcome.

146. Minor liver profile dysfunctions in Plasmodium vivax, P. malaria and P. ovale patients and normalization after treatment.

147. Population pharmacokinetics of artesunate and dihydroartemisinin following intra-rectal dosing of artesunate in malaria patients.

148. Travelers' malaria among foreigners at the Hospital for Tropical Diseases, Bangkok, Thailand - a 6-year review (2000-2005).

149. Safety and tolerability of elubaquine (bulaquine, CDRI 80/53) for treatment of Plasmidium vivax malaria in Thailand.

150. Monocyte chemoattractant protein 1 (MCP-1) gene polymorphism is not associated with severe and cerebral malaria in Thailand.

Catalog

Books, media, physical & digital resources